Stock Market Reviews

QTRX (Quanterix Corporation) News

Get the latest news, insights, and market updates on QTRX (Quanterix Corporation). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Quanterix Corp (QTRX) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...
  Quanterix Corp (QTRX) reports steady revenue amidst market challenges, with significant strides in Alzheimer's diagnostics and integration synergies.
  Nov 11, 2025 - $QTRX
• Alzheimer Biomarker Based Diagnostic Research Report 2025-2035: Market to Transform with Rise of Blood-Based Tests, Emerging as a Less Invasive and Scalable Alternative to CSF and PET Methods
  Alzheimer biomarker-based diagnostics focus on identifying key biomarkers like amyloid plaques and tau tangles in biological fluids and through imaging, enhancing early detection and management of Alzheimer's disease (AD). These advanced techniques, including CSF analysis, PET, and MRI, enable early intervention and tailored treatments, albeit with challenges like high costs and limited accessibility. The market for these diagnostics is driven by an aging population and rising AD prevalence, spu
  Nov 11, 2025 - $QTRX
• Quanterix Releases Financial Results for the Third Quarter of 2025
  BILLERICA, Mass., November 10, 2025--Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced financial results for the third quarter ended September 30, 2025.
  Nov 10, 2025 - $QTRX
• Quanterix Corporation (QTRX) Reports Q3 Loss, Tops Revenue Estimates
  Quanterix (QTRX) delivered earnings and revenue surprises of -56.52% and +4.18%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
  Nov 10, 2025 - $QTRX
• Sanuwave Health Inc. (SNWV) Beats Q3 Earnings and Revenue Estimates
  Sanuwave Health (SNWV) delivered earnings and revenue surprises of +43.75% and +0.18%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
  Nov 7, 2025 - $QTRX
• Quanterix To Report Third Quarter 2025 Financial Results on November 10, 2025
  BILLERICA, Mass., November 03, 2025--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conference call on Monday, November 10, 2025, at 4:30 p.m. E.T., to discuss its third quarter 2025 financial results.
  Nov 3, 2025 - $QTRX
• Even after rising 16% this past week, Quanterix (NASDAQ:QTRX) shareholders are still down 86% over the past five years
  This month, we saw the Quanterix Corporation ( NASDAQ:QTRX ) up an impressive 34%. But spare a thought for the long...
  Oct 6, 2025 - $QTRX
• All You Need to Know About Quanterix (QTRX) Rating Upgrade to Buy
  Quanterix (QTRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
  Oct 2, 2025 - $QTRX
• Quanterix Corporation (NASDAQ:QTRX) is favoured by institutional owners who hold 67% of the company
  Key Insights Given the large stake in the stock by institutions, Quanterix's stock price might be vulnerable to their...
  Sep 5, 2025 - $QTRX
• Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit
  BILLERICA, Mass., August 21, 2025--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced the New York State Department of Health (NYSDOH) has granted the Quanterix Accelerator Laboratory a clinical laboratory permit in the Clinical Chemistry category. The permit approval expands advanced biomarker research led by Quanterix, deepening collaborations with clinical, pharmaceutical, and research partners. The Quanteri
  Aug 21, 2025 - $QTRX